CNS Response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated egfr-mutated advanced non-small-cell lung cancer - Reungwetwattana, T; Nakagawa, K; Cho, B C (J Clin Oncol, 2018)
et al.